451 related articles for article (PubMed ID: 1695013)
1. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
3. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the existence and biological role of L-arginine/nitric oxide pathway in human platelets by spin-trapping/EPR studies.
Prónai L; Ichimori K; Nozaki H; Nakazawa H; Okino H; Carmichael AJ; Arroyo CM
Eur J Biochem; 1991 Dec; 202(3):923-30. PubMed ID: 1662618
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease.
Riddell DR; Graham A; Owen JS
J Biol Chem; 1997 Jan; 272(1):89-95. PubMed ID: 8995232
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation.
Salvemini D; Masini E; Anggard E; Mannaioni PF; Vane J
Biochem Biophys Res Commun; 1990 Jun; 169(2):596-601. PubMed ID: 1972620
[TBL] [Abstract][Full Text] [Related]
7. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
9. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
[TBL] [Abstract][Full Text] [Related]
10. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.
Shen YC; Hong CY
Br J Pharmacol; 1995 Sep; 116(1):1644-8. PubMed ID: 8564231
[TBL] [Abstract][Full Text] [Related]
11. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.
Marietta M; Facchinetti F; Neri I; Piccinini F; Volpe A; Torelli G
Thromb Res; 1997 Oct; 88(2):229-35. PubMed ID: 9361375
[TBL] [Abstract][Full Text] [Related]
12. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase.
Mollace V; Salvemini D; Anggard E; Vane J
Br J Pharmacol; 1991 Nov; 104(3):633-8. PubMed ID: 1724627
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
15. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
Faint RW; Mackie IJ; Machin SJ
Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
[TBL] [Abstract][Full Text] [Related]
16. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
[TBL] [Abstract][Full Text] [Related]
17. Increase in activating ability of human platelet guanylate cyclase during aggregation.
Severina IS; Belushkina NN
Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
[TBL] [Abstract][Full Text] [Related]
19. Variations in the platelet arginine/nitric oxide pathway during the ovarian cycle in females affected by menstrual migraine.
Sarchielli P; Tognoloni M; Russo S; Vulcano MR; Feleppa M; Malà M; Sartori M; Gallai V
Cephalalgia; 1996 Nov; 16(7):468-75. PubMed ID: 8933990
[TBL] [Abstract][Full Text] [Related]
20. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets.
Fleming I; Schulz C; Fichtlscherer B; Kemp BE; Fisslthaler B; Busse R
Thromb Haemost; 2003 Nov; 90(5):863-71. PubMed ID: 14597982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]